CN102212146A - 一种侧链用硫辛酸修饰的亲水性聚合物 - Google Patents
一种侧链用硫辛酸修饰的亲水性聚合物 Download PDFInfo
- Publication number
- CN102212146A CN102212146A CN2011101109864A CN201110110986A CN102212146A CN 102212146 A CN102212146 A CN 102212146A CN 2011101109864 A CN2011101109864 A CN 2011101109864A CN 201110110986 A CN201110110986 A CN 201110110986A CN 102212146 A CN102212146 A CN 102212146A
- Authority
- CN
- China
- Prior art keywords
- polymer
- hydrophilic polymer
- thioctic acid
- nanoparticle
- crosslinked
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001477 hydrophilic polymer Polymers 0.000 title claims abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 39
- 229920002307 Dextran Polymers 0.000 claims description 18
- 239000005864 Sulphur Substances 0.000 claims description 15
- 238000006467 substitution reaction Methods 0.000 claims description 11
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 239000002105 nanoparticle Substances 0.000 abstract description 87
- 239000003814 drug Substances 0.000 abstract description 29
- 210000004027 cell Anatomy 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 8
- 238000001338 self-assembly Methods 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 229920006037 cross link polymer Polymers 0.000 abstract description 4
- 238000001727 in vivo Methods 0.000 abstract description 4
- 230000009467 reduction Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 3
- 210000004881 tumor cell Anatomy 0.000 abstract description 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000003368 amide group Chemical group 0.000 abstract 1
- 235000019136 lipoic acid Nutrition 0.000 description 32
- 229960002663 thioctic acid Drugs 0.000 description 32
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 30
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 28
- 238000000034 method Methods 0.000 description 27
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 24
- 238000004132 cross linking Methods 0.000 description 23
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical group OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- -1 polyoxyethylene Polymers 0.000 description 15
- 229910052786 argon Inorganic materials 0.000 description 14
- 239000000126 substance Substances 0.000 description 13
- 239000008186 active pharmaceutical agent Substances 0.000 description 12
- 238000000502 dialysis Methods 0.000 description 12
- 230000002209 hydrophobic effect Effects 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 9
- 238000009826 distribution Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 7
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 239000003937 drug carrier Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 229920001610 polycaprolactone Polymers 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- FBTUMDXHSRTGRV-ALTNURHMSA-N zorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(\C)=N\NC(=O)C=1C=CC=CC=1)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 FBTUMDXHSRTGRV-ALTNURHMSA-N 0.000 description 4
- 229960000641 zorubicin Drugs 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 230000002121 endocytic effect Effects 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000005311 nuclear magnetism Effects 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002296 dynamic light scattering Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 239000004632 polycaprolactone Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- ANHAEBWRQNIPEV-UHFFFAOYSA-N 2-chloroethyl dihydrogen phosphate Chemical compound OP(O)(=O)OCCCl ANHAEBWRQNIPEV-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002539 nanocarrier Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 150000003018 phosphorus compounds Chemical class 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110110986 CN102212146B (zh) | 2009-07-23 | 2009-07-23 | 一种侧链用硫辛酸修饰的亲水性聚合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110110986 CN102212146B (zh) | 2009-07-23 | 2009-07-23 | 一种侧链用硫辛酸修饰的亲水性聚合物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101819226A Division CN101665569B (zh) | 2009-07-23 | 2009-07-23 | 侧链用硫辛酸修饰的亲水性聚合物及其制备和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102212146A true CN102212146A (zh) | 2011-10-12 |
CN102212146B CN102212146B (zh) | 2013-02-13 |
Family
ID=44743708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110110986 Active CN102212146B (zh) | 2009-07-23 | 2009-07-23 | 一种侧链用硫辛酸修饰的亲水性聚合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102212146B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104004001A (zh) * | 2014-05-28 | 2014-08-27 | 苏州大学 | 含双硫五元环功能基团的环状碳酸酯单体及其制备方法 |
CN104497171A (zh) * | 2015-01-07 | 2015-04-08 | 苏州大学 | 基于透明质酸的两亲聚合物、其制备方法与应用 |
CN108392471A (zh) * | 2018-03-01 | 2018-08-14 | 苏州大学张家港工业技术研究院 | 基于末端含硫辛酰基星型聚合物的纳米药物 |
CN109700779A (zh) * | 2018-09-14 | 2019-05-03 | 苏州科技大学 | 复合巯基改性壳聚糖的可降解聚合物微球 |
CN110387142A (zh) * | 2019-08-14 | 2019-10-29 | 桂林理工大学 | 一种负载有脂溶性色素的桃胶多糖纳米球的制备方法 |
CN113208113A (zh) * | 2021-05-08 | 2021-08-06 | 杭州诺莘科技有限责任公司 | 肉桂酸、硫辛酸共接枝壳聚糖修饰的nmn脂质体及其制备和应用 |
CN114790377A (zh) * | 2021-06-08 | 2022-07-26 | 天津大学 | 一种超支化的聚合物压敏胶及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2385867C (en) * | 1999-10-01 | 2009-09-01 | Skw Trostberg Aktiengesellschaft | Sustained release form comprising alpha-lipoic acid or derivatives thereof |
CN100398554C (zh) * | 2002-09-09 | 2008-07-02 | 独立行政法人科学技术振兴机构 | 链化合物和配体、及其制备方法 |
CA2848648C (en) * | 2006-06-02 | 2017-10-10 | Synedgen, Inc. | Chitosan-derivative compounds and methods of controlling microbial populations |
EP2125775A4 (en) * | 2007-03-01 | 2011-07-13 | Cedars Sinai Medical Center | ANTIOXIDATION POLYMERS WITH [1,2] -DITHIOLANTEILES AND THEIR USE |
ITMI20072416A1 (it) * | 2007-12-21 | 2009-06-22 | Sigea Srl | Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali |
-
2009
- 2009-07-23 CN CN 201110110986 patent/CN102212146B/zh active Active
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104004001B (zh) * | 2014-05-28 | 2016-03-30 | 苏州大学 | 含双硫五元环功能基团的环状碳酸酯单体及其制备方法 |
CN104004001A (zh) * | 2014-05-28 | 2014-08-27 | 苏州大学 | 含双硫五元环功能基团的环状碳酸酯单体及其制备方法 |
CN104497171A (zh) * | 2015-01-07 | 2015-04-08 | 苏州大学 | 基于透明质酸的两亲聚合物、其制备方法与应用 |
WO2016110228A1 (zh) * | 2015-01-07 | 2016-07-14 | 博瑞生物医药(苏州)股份有限公司 | 基于透明质酸的两亲聚合物、其制备方法与应用 |
CN108392471B (zh) * | 2018-03-01 | 2020-06-16 | 苏州大学张家港工业技术研究院 | 基于末端含硫辛酰基星型聚合物的纳米药物 |
CN108392471A (zh) * | 2018-03-01 | 2018-08-14 | 苏州大学张家港工业技术研究院 | 基于末端含硫辛酰基星型聚合物的纳米药物 |
CN109700779A (zh) * | 2018-09-14 | 2019-05-03 | 苏州科技大学 | 复合巯基改性壳聚糖的可降解聚合物微球 |
CN110387142A (zh) * | 2019-08-14 | 2019-10-29 | 桂林理工大学 | 一种负载有脂溶性色素的桃胶多糖纳米球的制备方法 |
CN110387142B (zh) * | 2019-08-14 | 2021-08-17 | 桂林理工大学 | 一种负载有脂溶性色素的桃胶多糖纳米球的制备方法 |
CN113208113A (zh) * | 2021-05-08 | 2021-08-06 | 杭州诺莘科技有限责任公司 | 肉桂酸、硫辛酸共接枝壳聚糖修饰的nmn脂质体及其制备和应用 |
CN113208113B (zh) * | 2021-05-08 | 2022-08-09 | 杭州诺莘科技有限责任公司 | 肉桂酸、硫辛酸共接枝壳聚糖修饰的nmn脂质体及其制备和应用 |
CN114790377A (zh) * | 2021-06-08 | 2022-07-26 | 天津大学 | 一种超支化的聚合物压敏胶及其制备方法和应用 |
CN114790377B (zh) * | 2021-06-08 | 2023-06-16 | 天津大学 | 一种超支化的聚合物压敏胶及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102212146B (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101665569B (zh) | 侧链用硫辛酸修饰的亲水性聚合物及其制备和应用 | |
Li et al. | Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel | |
Jia et al. | Multi-functionalized hyaluronic acid nanogels crosslinked with carbon dots as dual receptor-mediated targeting tumor theranostics | |
CN102212146B (zh) | 一种侧链用硫辛酸修饰的亲水性聚合物 | |
CN104497171B (zh) | 基于透明质酸的两亲聚合物、其制备方法与应用 | |
CN106727307B (zh) | 一种还原敏感纳米胶束的制备及应用 | |
CN110237035B (zh) | 一种主动靶向型两亲性多肽纳米药物载体及其制备与应用 | |
Meng et al. | Synthesis and characterization of curcumin-loaded pH/reduction dual-responsive folic acid modified carboxymethyl cellulose-based microcapsules for targeted drug delivery | |
CN105524272B (zh) | 硫辛酸修饰的聚乙二醇-聚氨基酸嵌段共聚物的制备和应用 | |
Han et al. | Redox-sensitive micelles for targeted intracellular delivery and combination chemotherapy of paclitaxel and all-trans-retinoid acid | |
CN103143027A (zh) | 一种基于透明质酸的双靶向纳米复合物药物制备及其应用 | |
Li et al. | Fabrication of a multi-level drug release platform with liposomes, chitooligosaccharides, phospholipids and injectable chitosan hydrogel to enhance anti-tumor effectiveness | |
CN104262638A (zh) | 透明质酸-胱胺-聚乳酸-羟基乙酸接枝聚合物及其制备方法 | |
CN102114246A (zh) | 生物体病灶部位特异性释药的两亲性多糖衍生物载体及其药学组合物的制备和应用 | |
CN103435718A (zh) | Peg修饰的透明质酸胆固醇酯 | |
CN105524271A (zh) | 胆酸修饰的聚氨基酸嵌段共聚物的合成及应用 | |
CN106137962B (zh) | 一种负载卡莫司汀的胶质瘤靶向聚合物胶束及其制备方法 | |
CN111870579B (zh) | 一种肿瘤靶向纳米胶束、制备方法及作为药物载体的应用 | |
CN105859990B (zh) | 侧链含硫辛酰基的聚合物、其制备方法及由其制备的聚合物囊泡及其应用 | |
CN102309760A (zh) | 一种阳离子型两亲性壳聚糖纳米药物载体及其制备和应用 | |
KR100831391B1 (ko) | pH 민감성 이미다졸 그룹을 함유한 키토산 복합체 및 그제조방법 | |
CN104398504B (zh) | 一种去氧鬼臼毒素类药物的药物组合物及其制备方法和制剂 | |
CN112156066B (zh) | 一种包含胶束的可注射复合水凝胶双载药系统的制备方法 | |
CN108186571A (zh) | 可逆交联不对称囊泡在制备治疗急性白血病药物中的应用 | |
CN112675314A (zh) | 一种骨靶向纳米胶束递送系统及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BORUI BIO-MEDICINE TECHNOLOGY (SUZHOU) CO., LTD. Free format text: FORMER OWNER: SUZHOU UNIVERSITY Effective date: 20150601 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150601 Address after: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215123 No. 218 BioBAY building C27 Patentee after: Borui Bio-medical Technology (Jiangsu) Co., Ltd. Address before: 215123 Suzhou City, Suzhou Province Industrial Park, No. love road, No. 199 Patentee before: Soochow University |
|
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: Suzhou City, Jiangsu Province, Suzhou Industrial Park 215123 Xinghu Street No. 218 Nano Technology Park building C25 Patentee after: Borui Pharmaceutical (Suzhou) Limited by Share Ltd Address before: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215123 No. 218 BioBAY building C27 Patentee before: Borui Bio-medical Technology (Jiangsu) Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20201217 Address after: 22 Binjiang South Road, Taixing Economic Development Zone, Taizhou City, Jiangsu Province Patentee after: BRIGHTGENE BIO-MEDICAL TECHNOLOGY Co.,Ltd. Patentee after: Borui biomedical (Suzhou) Co.,Ltd. Address before: Building C25, nanotechnology Park, 218 Xinghu street, Suzhou Industrial Park, Jiangsu Province Patentee before: Borui biomedical (Suzhou) Co.,Ltd. |
|
TR01 | Transfer of patent right |